Advertisement
Bio-Techne Corporation

Bio-Techne Corporation (TECH) Stock Overview

Explore Bio-Techne Corporation’s financial performance, market position, analyst ratings, and future outlook.

TECHNASDAQ
HealthcareBiotechnology
$58.88
$2.62(4.66%)
U.S. Market opens in 7h 45m
Advertisement

Bio-Techne Corporation (TECH)

Meyka AI Score

Z

Key Financials

Market Cap9.2B
P/E Ratio83.62
EPS (TTM)$0.70
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$57.07
3 Months$58.59
1 Year Target$54.81

TECH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bio-Techne Corporation (TECH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.14, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $54.81.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 83.62 and a market capitalization of 9.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.65%
5-Day Change
1.26%
1-Month Change
22.12%
3-Month Change
12.29%
6-Month Change
-0.53%
Year-to-Date (YTD) Change
0.11%
1-Year Change
17.75%
3-Year Change
-23.33%
5-Year Change
-46.42%
All-Time (Max) Change
53726.11%

Contact Information

612 379 8854
614 McKinley Place N.E., Minneapolis, MN, 55413

Company Facts

31,000 Employees
IPO DateFeb 9, 1989
CountryUS
Actively Trading

Frequently Asked Questions